$1.09B
$244,000
0.0% of portfolio
29,674
Q4 2024
Added 22.17%
$3.04B
$407,000
0.0% of portfolio
9,665
Q4 2024
Reduced 21.51%
$3.11B
$374,000
0.0% of portfolio
142,151
Q4 2024
New
$30.8B
$168,000
0.0% of portfolio
763
Q4 2024
Reduced 99.56%
$216M
$190,000
0.0% of portfolio
14,823
Q4 2024
New
$47.3B
$806,000
0.0% of portfolio
1,356
Q4 2024
Reduced 66.48%
$450M
$189,000
0.0% of portfolio
11,102
Q4 2024
Added 14.51%
$3.12B
$1.07 Million
0.0% of portfolio
27,955
Q4 2024
Added 462.02%
$372M
$120,000
0.0% of portfolio
4,486
Q4 2024
New
$499M
$115,000
0.0% of portfolio
454
Q4 2024
New
$7.17B
$590,000
0.0% of portfolio
32,597
Q4 2024
Reduced 28.23%
-
$31,000
0.0% of portfolio
-
Q4 2024
New
$303M
$147,000
0.0% of portfolio
5,904
Q4 2024
New
$4.2B
$312,000
0.0% of portfolio
6,503
Q4 2024
New
$740M
$162,000
0.0% of portfolio
28,715
Q4 2024
Reduced 0.47%
$7.21B
$240,000
0.0% of portfolio
1,816
Q4 2024
Reduced 32.62%
$682M
$134,000
0.0% of portfolio
4,649
Q4 2024
New
$6.75B
$305,000
0.0% of portfolio
25,991
Q4 2024
Reduced 54.28%
$1.87B
$456,000
0.0% of portfolio
24,319
Q4 2024
Added 14.34%
$257M
$103,000
0.0% of portfolio
19,717
Q4 2024
Added 31.62%
Canadian Pacific Kansas City Com
-
$997,000
0.0% of portfolio
-
Q4 2024
Added 44.4%
$638M
$951,000
0.0% of portfolio
85,545
Q4 2024
Added 24.47%
$848M
$194,000
0.0% of portfolio
32,890
Q4 2024
Reduced 29.06%
$433M
$173,000
0.0% of portfolio
9,838
Q4 2024
Added 23.61%
$185M
$192,000
0.0% of portfolio
14,646
Q4 2024
Added 83.19%
$183M
$171,000
0.0% of portfolio
106,135
Q4 2024
Reduced 0.8%
$280M
$119,000
0.0% of portfolio
7,739
Q4 2024
New
$13.2B
$295,000
0.0% of portfolio
3,475
Q4 2024
Added 2.21%
$242M
$121,000
0.0% of portfolio
1,919
Q4 2024
New
$454M
$164,000
0.0% of portfolio
5,297
Q4 2024
Added 45.48%
-
$154,000
0.0% of portfolio
6,302
Q4 2024
Reduced 60.73%
$3.07B
$112,000
0.0% of portfolio
6,554
Q4 2024
Reduced 85.17%
$0
$732,000
0.0% of portfolio
31,087
Q4 2024
Reduced 81.25%
$1.5B
$182,000
0.0% of portfolio
8,610
Q4 2024
Reduced 44.48%
$4.77B
$621,000
0.0% of portfolio
6,832
Q4 2024
Reduced 32.53%
$2.07B
$552,000
0.0% of portfolio
4,192
Q4 2024
Added 320.46%
$1.66B
$371,000
0.0% of portfolio
16,863
Q4 2024
Added 27.11%
$845M
$371,000
0.0% of portfolio
7,195
Q4 2024
Reduced 7.51%
$4.62B
$195,000
0.0% of portfolio
3,110
Q4 2024
Reduced 83.63%
$678M
$374,000
0.0% of portfolio
34,844
Q4 2024
Added 25.76%
$1.63B
$1.07 Million
0.0% of portfolio
109,524
Q4 2024
New
$4.84B
$288,000
0.0% of portfolio
2,978
Q4 2024
Reduced 64.52%
$422M
$203,000
0.0% of portfolio
11,940
Q4 2024
Added 44.99%
$291M
$131,000
0.0% of portfolio
22,175
Q4 2024
Added 5.61%
Arrivent Biopharma Inc Com
-
$315,000
0.0% of portfolio
-
Q4 2024
Reduced 1.01%
$307M
$134,000
0.0% of portfolio
13,133
Q4 2024
New
-
$178,000
0.0% of portfolio
-
Q4 2024
Reduced 88.15%
$4.67B
$408,000
0.0% of portfolio
64,732
Q4 2024
Reduced 62.22%
$1.99B
$533,000
0.0% of portfolio
7,630
Q4 2024
Added 10.71%
$7.46B
$767,000
0.0% of portfolio
16,162
Q4 2024
Reduced 47.62%